Department of Medical Oncology, Erzincan Binali Yildirim University Medical School, Erzincan, 24000, Turkey.
Department of Internal Medicine, Capital Health Regional Medical Center, Trenton, NJ 08638, USA.
Future Oncol. 2021 Jul;17(20):2621-2629. doi: 10.2217/fon-2021-0020. Epub 2021 Apr 21.
The aim of this study was to assess the impact of coronaphobia on treatment and follow-up compliance in cancer patients. The records of 230 cancer patients were reviewed. Coronaphobia was assessed via the validated COVID-19 Phobia Scale (C19P-S). A total of 64% of the patients had a high coronaphobia score. Among them, 59% were noncompliant. In multivariate logistic regression analysis, low educational status, treatment type, following COVID-19 news, having knowledge about COVID-19 transmission and higher C19P-S score were associated with noncompliance (p = 0.006, p < 0.001, p = 0.002, p = 0.002 and p = 0.001, respectively). Multivariate analysis revealed that having knowledge about COVID-19 transmission was related to a higher C19P-S score (p = 0.001). The cancer patients studied had significant coronaphobia. Moreover, greater coronaphobia was significantly associated with noncompliance with follow-up and treatment.
本研究旨在评估恐冠症对癌症患者治疗和随访依从性的影响。回顾了 230 例癌症患者的记录。通过经过验证的 COVID-19 恐惧症量表（C19P-S）评估恐冠症。64%的患者有较高的恐冠症评分。其中，59%的患者不依从。在多变量逻辑回归分析中，低教育程度、治疗类型、关注 COVID-19 新闻、了解 COVID-19 传播途径以及较高的 C19P-S 评分与不依从相关（p=0.006、p<0.001、p=0.002、p=0.002 和 p=0.001）。多变量分析显示，了解 COVID-19 传播途径与较高的 C19P-S 评分相关（p=0.001）。研究中的癌症患者存在明显的恐冠症。此外，较高的恐冠症与随访和治疗的不依从显著相关。
